Molecular biology and clinical implications of the adenomatous polyposis coli [APC] gene

• Autorzy: Miturski R. , Burnouf D. , Nothisen M. , Bogusiewicz M. , Jakowicki J.A.
• Języki publikacji: EN

Abstrakty

EN

This review describes the structure of the adenomatous polyposis coli (APC) gene with expressed proteins and their possible tissue interactions. The functions of APC in animals and humans are discussed. The mutational spectrum with clinical impact on colon pathology and gynaecological pathology similarities are presented, along with a discussion of a highly sensitive molecular biology test.

Słowa kluczowe

EN

gene; adenomatous polyposis coli; structure; mutation; colon; tissue interaction; pathology

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2000
• Tom: 05
• Numer: 1
• Opis fizyczny: p.3-18,fig.

Twórcy

autor

Miturski R.

• Lublin School of Medicine, Jaczewskiego 8, 20-090 Lublin, Poland

autor

Burnouf D.

autor

Nothisen M.

autor

Bogusiewicz M.

autor

Jakowicki J.A.

Bibliografia

• 1. Leppert, M., Dobbs, M., Scambler, P., O’Connell, P., Nakamura, Y., Stauffer, D., Woodword, S., Burt, R., Hughes, J., Gardner, E. and White, R. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238 (1987) 1411-1413.
• 2. Santoro, I. M. and Groden, J. Alternative splicing of the APC gene and its association with terminal differentiation. Cancer Res. 57 (1997) 488-494.
• 3. Peifer, M. Regulating cell proliferation: As easy as APC. Science 272 (1996) 974-975.
• 4. Olschwang, S., Tiret, A., Laurent-Puig, P., Muleris, M, Parc, R and Thomas, G. Restriction of ocular fundus lesion to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 75 (1993) 995-68.
• 5. Näthke, I. S., Adams, C. L., Polakis, P., Sellin, J. H. and Nelson, W. J. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell. Biol. 134 (1996) 165-179.
• 6. Su, L. K., Vogelstein, B. and Kinzler, KW. Association of the APC tumor suppressor protein with catenins. Science 262 (1993) 1734-1737.
• 7. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, KW. Activation of β-catenin-Tcf signaling in colon cancer by mutation in or APC. Science 275 (1997) 1787-1790.
• 8. Pyles, R. B., Santoro, I. M., Groden, J. and Parysek, L. M. Novel protein isoforms of the APC tumor suppressor in neural tissue. Oncogene 16 (1998) 77-82.
• 9. White, R. L. Colon cancer. Molecular biology of the APC protein. Pathol. Biol. 45 (1997) 240-244.
• 10. Peifer, M. β-catenin as oncogene: the smoking gun. Science 275 (1997) 1752-1753.
• 11. Kinzler, K. W. and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170.
• 12. Miller, J. R. and Moon, R. T. Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev. 15 (1996) 2527-2539.
• 13. Moon, R. T., Brown, J. D. and Torres, M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 13 (1997) 157- 162.
• 14. Willert, K. and Nusse, R. β-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8 (1998) 95-102.
• 15. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382 (1996) 638-642.
• 16. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsare, S., Korinek, V., Roose, J., Destree, O. and Clevers, H. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391-399.
• 17. Korinek, V., Barker, N., Morin, P. J., van Wiche, D., de Weger, R. and Kinzler, K. W., Vogelstein, B. and Clevers, H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC sup -/- colon carcinoma. Science 275 (1997) 1784-1787.
• 18. He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B. and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512.
• 19. Munemitsu, S., Albert, i., Rubinfeld, B. and Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA. 28 (1995) 3046- 3050.
• 20. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S. and Polakis, P. Binding of GSK-3-β to the APC-β-catenin complex and regulation of complex assembly. Science 272 (1996) 1023-1026.
• 21. Zeng, Li., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T. J., Perry III, W. L., Lee. J. J., Tilghman, S. M., Gumbiner, B. M. and Costantini, F. The mouse Fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90 (1997) 181-192.
• 22. Behrens, J., Jerchow, B-A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D. and Birchmeier W. Functional interaction of an axin homolog, conductin, with β-catenin, and GSK3β. Science 280 (1998) 596-599.
• 14. Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M., Sakamoto, I., Koyama, S. and Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, directly interacts with adenomatous coli and regulates the stabilization of β-catenin. J. Biol. Chem. 273 (1998) 10823-10826.
• 24. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. and Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-ddependent phosphorylation of β-catenin. EMBO J. 17 (1998) 1371-1384.
• 25. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B. and Polakis, P. Downregulation of β-catenin and its association with the APC tumor suppressor, β-catenin and GSK3β. Curr. Biol. 8 (1998) 573-581.
• 26. Hamada, F., Tomoyasu, Y., Takatsu, Y., Nakamura M., Nagai, S., Suzuki, A., Fuijta F., Shibuya, H., Toyoshima, K., Ueno, N. and Akiyama T. Negative regiulation od Wingless signaling by D-Axin, a Drosophila homolog of Axin. Science 283 (1999) 1739-1742.
• 27. Lue, R. A., Marfatia, S. M, Branton, D. and Chishti, A. H. Cloning and charactrization of hdlg: the human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1. Proc. Natl. Acad. Sci. USA 91 (1994) 9818-9822.
• 28. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451-1455.
• 29. Larue, A., Antos, C., Butz, S., Huber, O., Delmas, V., Dominis, M. and Kemler, R. A role for cadherins in tissue formation. Development 122 (1996) 3185-3194.
• 30. Hubner, O., Bierkamp, C. and Kemler, R. Cadherins and catenins in development Curr. Opin. Cell. Biol. 8 (1996) 685-691.
• 31. Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., Takeichi, M. and Mori, T. Cancer Res. 53 (1993) 1696-1701.
• 32. Takeichi, M. Cadherins and cancer: implications for invasion and metastasis. Curr. Opin. Cell. Biol. 5 (1993) 806-811.
• 33. Oyama, T., Kanai, Y., Ochiai, A., Akimoto, S., Oda, T., Yanagihara, K., Nagafuchi, A., Tsukita, S., Shibamoto, S., Ito, F., Takeichi M., Matsuda, H. and Hirohashi, S. A truncated β-catenin disrupts the interaction between E- cadherin and α-catenin: a cause of loss of intercellular adhesivness in human cancer cell lines. Cancer Res. 54 (1994) 6282-6287.
• 34. McCrea, P. D., Turck, C. W. and Gumbiner, B. A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 254 (1991) 1359-1361.
• 35. Ozawa, M., Ringwald, M. and Kemler, R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytolpasmic region of the call adhesion molecule. Proc. Natl. Acad. Sci. USA 87 (1990) 4246-4250.
• 36. Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R. and Hoschuetzky H. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell. Sci. 107 (1994) 3655-3663.
• 37. Jou, T. S., Stappert, J, Nelson, W. J. and Marrs, J. A. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc. Natl. Acad. Sci. USA 92 (1995) 5067-5071.
• 38. Rubinfeld, B., Souza, B., Albert, I., Munemitsu, S. and Polakis, P. The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J. Biol. Chem. 270 (1995) 5549-5555.
• 39. Hulsken, J., Birchmeier, W. and Behrens, J. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J. Cell. Biol. 127 (1994) 2061-2069.
• 40. Pollack, A. L., Bart, A. I. M., Altschuler, Y., Nelson, W. J. and Mostov, K. E. Dynamics of β-catenin interactions with APC protein regulate epithelial tubulogenesis. J. Cell. Biol. 137 (1997) 1651-1662.
• 41. Munemitsu, S., Souza, B., Muller, O., Albert, I., Rubinfeld, B. Polakis, P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 54 (1994) 3676-3681.
• 42. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B. and Kinzler, K. W. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 54 (1994) 3672-3675.
• 43. Polakis, P. Mutations in APC gene and their implications for proteine structure and function. Curr. Opin. Genet. Dev. 5 (1995) 66-71.
• 44. Su, L.-K., Burrel, M., Hill, D. E. Gyuris, J., Brent, R., Wiltshire, R., Trent, J. Vogelstein, B. and Kinzler K. W. APC bind to the novel protein EB-1. Cancer Res. 55 (1995) 2972-2977.
• 45. Hyman, A. A. and Karsenti, E. Morphogenetic propertis of microtubules and mitotic spindle assembly. Cell 84 (1996) 401-410.
• 46. Berrueta, L., Kraeft, S. K., Tirnauer, J. S., Schuyler, S. C., Chen, L. B., Hill, D. E., Pellman, D. and Bierer, B. E. The adenomatous polyposis coli- binding protein EB1 is associated with cytoplasmic and spindle microtubules. Proc. Natl. Acad. Sci. USA 95 (1998) 10596-10601.
• 47. Morrison, E. E., Wardleworth, B. N., Askham, J. M., Markham, A. F. and Meredith, D. M. EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle. Oncogene 17 (1998) 3471-3477.
• 48. Muhua, L., Adames, N. R., Murphy, M. D., Shields, C. R. and Cooper, J. A. A cytokinesis checkpoint requiring the yeast homologue of an APC-binding protein. Nature 393 (1998) 487-491.
• 49. Beinhauer, J. D., Hagan, I. M., Hegemann, J. H. and Fleig, U. Mal3, the fission yeast homologue of the human APC-binding protein EB-1 is required for microtubule integrity and the maintenance of cell form. J. Cell. Biol. 139 (1997) 717-728.
• 50. Burchill, S. A. The tumor suppressor APC gene product is associated with cell adhesion. BioEssays 16 (1994) 225-227.
• 51. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton S. R., Thibodeau, S. N., Vogelstein, B. and Kinzler, K. W. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992) 235-237.
• 52. Vogelstein, B. and Kinzler, K.W. The multistep nature of cancer. Trends Genet. 9 (1993) 138-141.
• 53. Prosser, J., Condie, A., Wright, M., Horn, J. M., Fontes, J. A., Wyllie, A. H. and Dunlop, M. G. APC mutation analysis by chemical cleveage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br. J. Cancer 70 (1994) 841-846.
• 54. Ransohoff, D. F. and Lang, C. A. Sreening for colorectal cancer. N. Engl. J. Med. 325 (1991) 37-41.
• 55. Cunningham, C. and Dunlop, M. G. Molecular genetic basis of colorectal cancer susceptibility. Br. J. Surg. 83 (1996) 321-329.
• 56. Nagase, H. and Nakamura, Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum. Mutat. 2 (1993) 425-434.
• 57. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T. and Nakamura, Y. Somatic mutations of the APC gene in colorectal tumours: mutation cluster region in the APC gene. Hum. Mol. Genet, 1 (1992) 229-233.
• 58. Béroud, C. and Soussi, T. APC gene: database of germline somatic mutations in human tumurs and cell lines. Nucl. Acids. Res. 24 (1996) 121-124.
• 59. Mandl, M., Paffenholz, R., Friedl, W., Caspari, R., Sengteller, M. and Propping, P. Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis. Hum. Mol. Genet. 3 (1994) 181-184.
• 60. Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J. H., Sugimura, T. and Nagao, M. Specific 5’-GGGA-3’→5’- GGA-3’ mutation of the Ape gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazolo[4,5-b]pyridine. Proc. Natl. Acad. Sci. USA 92 (1995) 910-914.
• 61. Nagao, M., Ushijima, T., Toyota, M., Inuoe, R. and Sugimura, T. Genetic changes induced by heterocyclic amines. Mutat. Res. 376 (1997) 161-167.
• 62. Bussey, H. Familial polyposis coli. Families studies, histopathology, differential diagnosis, and results of treatment. The John Hopkins Yale University Press, Baltimore, USA 1975.
• 63. Phillips, R. K. S., Spigelman, A. D. and Thomson, J. P. Familial adenomatous polyposis and other polyposis syndromes. (E. Arnold, E., Ed,) London, UK, 1994.
• 64. Spirio, L., Olschwang, S., Groden, J., Robertson, M., Somowitz, W., Joslyn, G., Gelbert, L., Thliveris, A., Carlson, M., Otterud, B., Lynch, H., Watson, P., Lynch, P., Laurent-Puig, P., Burt R., Hughes, J. P., Thomas, G., Leppert, M. and White R. Alleles of the APC gene: An attenuated form of familial polyposis. Cell, 75 (1993) 951-957.
• 65. Davies, D., Armstrong, J., Thakker, n., Homer, K., Guy, S., Clancy, T., Sloan, p., Blair, V., Dodd, C. and Warnes, T. Severe Gardner sydrome in families with mutations restricted to a specific region of the APC gene. Am. J. Hum. Genet. 57 (1995) 1151-1158.
• 66. Hamilton, S. R., Liu, B., Parsons, R. E., Papadopulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., Burger, P. C., Wood, P. A., Taqi, F., Booker, S. V, Petersen, G. M., Offerhaus, G. J. A., Tersmette, A. C., Giarediello, F. M., Vogelstein, B. and Kinzler, K. W. The molecular basis of Turcot’s syndrome. N. Engl. J. Med. 332 (1995) 839-847.
• 67. Oda, H., Imai, Y., Nakatsuru, Y., Hata, J. and Ishikawa, T. Somatic mutations of the APC gene in sporadic hepatoblastoma. Cancer Res. 56 (1996) 3320-3323.
• 68. Soravia, C., Sugg, S. L., Berk, T., Mitri, A., Cheng, H., Gallinger, S., Cohen, Z., Asa, S. L. and Bapat, B. V. Familial adenomatous polyposis- associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am. J. Pathol. 154 (1999) 127-135.
• 69. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Hagase, H., Ando, H., Yanagisawa, A., Tsuchiya, E., Kato, Y. and Nakamura, Y. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res. 52 (1992) 6696-6698.
• 70. Bapat, B., Odze, R., Mitri, A., Berk, T., Ward, M. and Gallinger, S. Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP). Hum. Mol. Genet. 2 (1993) 1957-1959.
• 71. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Hagase, H., Kato, Y., Yanagisawa, A. and Nakamura, Y. The APC gene, responsible for familial adenomatous polyposis, is mutatedin human gastric cancer. Cancer Res. 52 (1992) 3231-3233.
• 72. Boynton, R. F., Blount, P. L., Yin, J., Brown, V. L., Huang, Y., Tong, Y., McDaniel, T., Newkirk, C., Resau, J. H., Raskind, W. H., Haggitt, R. C., Reid, B. and Meltzer S. J. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophaegal cancers. Proc. Natl. Acad. Sci. USA 89 (1992) 3385-3388.
• 73. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Hailing, K. C., Keeny, G., Podratz, K. C. and Jenkins, R. B. Human epithelial ovarian cancer allelotype. Cancer Res. 53 (1993) 2393-2398.
• 74. Tavassoli, M., Steingrimsdottir, H., Pierce, E., Jiang, X., Alagoz, M., Farzane, and Campbell, I. G. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequenly accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Br. J. Cancer 74 (1996) 115- 119.
• 75. Jeyarajach, A., Oram, D. and Jacobs, I. Molecular events in endometrial carcinogenesis. Int. J. Gynecol. Cancer 6 (1996) 425
• 76. Lynch, H. T., Smyrk, T. and Lynch, J. An update of HNPCC (Lynch syndrome) Cancer Genet. Cytogenet. 93 (1997) 84-99.
• 77. Boltenberg, A., Furgyik, S., and Kullander, S. Familial cancer aggregation in cases of adenocarcinoma corporis uteri. Acta Obstet. Gynecol. Scand. 69 (1990) 249-258.
• 78. Lynch, H. T., Krush, A. L., and Magnuson, C. W. Endometrial carcinoma: multiple primary malignances constitutional factors, and herdity. Am. J. Med. Sci. 36 (1966) 381-390.
• 79. Sandies, L. G., Hulman, L. P., Elias, S., Photopulos, G. J., Smiley, L. M., Posten, and Simpson, J. L. Endometrial adenocarcinoma: genetic analysis suggesting heritable site-specific uterine cancer. Gynecol. Oncol. 47 (1992) 167-171.
• 80. Cha, R. S., Zarbl, H., Keohavong, P. and Thilly, W. G. Mismatch amplification mutation assay (MAMA): aplication to the c-H-ras gene. PCR Methods Appl. 2 (1992) 14-20.
• 81. Miturski, R., Burnouf, D., Nothisen, M., Tomaszewski, J., Jakowicki, J. and Fuchs, R. APC gene is mutated in endometrial cancer of women. W. Mejbaum-Katzenellenbogen’s Seminars on Molecular Biology, Wrocław, 1998, Cell. Mol. Biol. Lett. 3 (1998) 185.
• 82. Fearon, E. and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 756-767